share_log

HCA Healthcare | 8-K: Current report

SEC ·  Aug 12 13:41

Summary by Moomoo AI

HCA Inc., a subsidiary of HCA Healthcare, completed a $3 billion public offering of senior notes on August 12, 2024. The offering includes $750 million of 5.450% notes due 2031, $1.25 billion of 5.450% notes due 2034, and $1 billion of 5.950% notes due 2054. These notes are fully guaranteed by HCA Healthcare on a senior unsecured basis.The notes were issued under an existing indenture with supplemental indentures. They rank senior to subordinated debt, equal to other senior debt, and are effectively subordinated to secured debt and structurally subordinated to subsidiary debt. The indentures include covenants limiting certain activities and provide for optional redemption and repurchase rights under specific conditions.This issuance increases HCA's long-term debt obligations. The notes are registered under the Securities Act and listed on the New York Stock Exchange, enhancing HCA's capital structure and liquidity position.
HCA Inc., a subsidiary of HCA Healthcare, completed a $3 billion public offering of senior notes on August 12, 2024. The offering includes $750 million of 5.450% notes due 2031, $1.25 billion of 5.450% notes due 2034, and $1 billion of 5.950% notes due 2054. These notes are fully guaranteed by HCA Healthcare on a senior unsecured basis.The notes were issued under an existing indenture with supplemental indentures. They rank senior to subordinated debt, equal to other senior debt, and are effectively subordinated to secured debt and structurally subordinated to subsidiary debt. The indentures include covenants limiting certain activities and provide for optional redemption and repurchase rights under specific conditions.This issuance increases HCA's long-term debt obligations. The notes are registered under the Securities Act and listed on the New York Stock Exchange, enhancing HCA's capital structure and liquidity position.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more